Investors with the goal of beating the broader market often turn to stock selection. Strategic choices in individual stocks can have a profound impact on your wealth.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
In the latest session, Karyopharm Therapeutics Inc (NASDAQ: KPTI) closed at $0.77 down -2.71% from its previous closing price of $0.79. In other words, the price has decreased by -$2.71 from its previous closing price. On the day, 0.67 million shares were traded. KPTI stock price reached its highest trading level at $0.7926 during the session, while it also had its lowest trading level at $0.7533.
Ratios:
For a deeper understanding of Karyopharm Therapeutics Inc’s stock, let’s take a closer look at its various ratios. For the most recent quarter (mrq), Quick Ratio is recorded 2.93 and its Current Ratio is at 3.00.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, Piper Sandler on January 19, 2023, initiated with a Overweight rating and assigned the stock a target price of $8.
On November 04, 2022, RBC Capital Mkts Upgraded its rating to Outperform which previously was Sector Perform and also upped its target price recommendation from $7 to $10.
JP Morgan Upgraded its Underweight to Neutral on February 09, 2022, while the target price for the stock was maintained at $8.
Insider Transactions:
Additionally, insider trades can be beneficial to investors who want to learn what the management thinks about stock prices in the future. A recent insider transaction in this stock occurred on Nov 05 ’24 when Paulson Richard A. sold 3,675 shares for $0.91 per share. The transaction valued at 3,346 led to the insider holds 1,131,932 shares of the business.
Paulson Richard A. sold 3,607 shares of KPTI for $3,172 on Oct 04 ’24. The President and CEO now owns 1,135,607 shares after completing the transaction at $0.88 per share. On Sep 04 ’24, another insider, Mano Michael, who serves as the SVP, General Counsel&Secretary of the company, sold 3,971 shares for $0.72 each. As a result, the insider received 2,866 and left with 273,881 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, KPTI now has a Market Capitalization of 96868496 and an Enterprise Value of 231101120. For the stock, the TTM Price-to-Sale (P/S) ratio is 0.65. Its current Enterprise Value per Revenue stands at 1.557 whereas that against EBITDA is -1.839.
Stock Price History:
Over the past 52 weeks, KPTI has reached a high of $1.95, while it has fallen to a 52-week low of $0.62. The 50-Day Moving Average of the stock is -6.36%, while the 200-Day Moving Average is calculated to be -24.30%.
Shares Statistics:
For the past three months, KPTI has traded an average of 752.57K shares per day and 767040 over the past ten days. A total of 114.92M shares are outstanding, with a floating share count of 114.64M. Insiders hold about 8.52% of the company’s shares, while institutions hold 47.48% stake in the company. Shares short for KPTI as of 1730332800 were 17693166 with a Short Ratio of 23.51, compared to 1727654400 on 18601001. Therefore, it implies a Short% of Shares Outstanding of 17693166 and a Short% of Float of 14.399999999999999.
